INS and diabetes mellitus: found that 12-week treatment with dapagliflozin improved insulin sensitivity, as assessed by serial measurements of plasma insulin and glucose levels adjusted for urinary glucose excretion, in a group of 24 adults with pre-diabetes undergoing oral glucose tolerant test (47).